About Impression Healthcare
Impression Healthcare Limited is an innovative healthcare company that sells customised oral devices both direct-to-the- consumer and via the Company’s growing B2B preferred practitioner network of dentists. With its own laboratory in Victoria, Australia, Impression offers best-in-class teeth-protection and helps its customers to combat bruxism, snoring, mild-to-moderate sleep apnoea and teeth discolouration with custom-fitted oral devices.
Impression has broadened its commitment to disruption in the healthcare sector by progressing multiple opportunities in the field of medicinal cannabis. IHL has its licenses in place to import, export and distribute cannabis products. In March of 2019, Impression executed a binding collaboration with Cannvalate to undertake four medicinal cannabis clinical trials. Cannvalate is Australia’s largest distributor of medicinal cannabis products.
IHL also has a collaboration agreement with leading US Cannabinoid therapeutics Company, AXIM Biotechnologies Incorporated.
Management & Board
Joel has over 13 years’ experience, with blue chip firms including Mars Foods, Tabcorp and Philip Morris International.
Prior to Joel’s appointment to CEO, he was the General Manager of Impression healthcare for a period of 3 years. During this time, he was instrumental in the marketing and procurement of multiple revenue-generating opportunities and collaborations, including with Pacific Smiles (ASX:PSQ), the NRL and AFL and implementation of Gameday’s ambassadorial program.
Al holds an Advanced Diploma Of Dental Prosthetics, with 16 years of experience in large-scale commercial dental laboratories across Western Australia and Victoria. As founder of Denture Innovations clinic and laboratory in 2009, he offered services to dentists and specialists nationwide, leading to the identification of the commercial opportunity within the Australian mouthguard market. Al is a member of the Australian Institute Of Company Directors.
Troy is a finance professional with over 23 years’ experience in stockbroking and corporate finance. Executive director of a boutique advisory firm; Alignment Capital Pty Ltd, with a broad range of experience and skills related to the management of ASX-listed emerging companies
Mr Widdows is a highly-experienced Fast-Moving Consumer Goods (FMCG) expert with over 17 years of experience in senior global executive positions at H.J. Heinz Corporation. Mr Widdows was the CEO and Managing Director of H.J. Heinz Company Australia between February 2003 and October 2008. During his tenure, Heinz Australia sales trebled, and the net profit grew by 5.5x. Following this, he moved into a regional CEO role covering Australasia and a large part of Asia with responsibility for 18,500 employees and revenues of US$1.8B. Mr Widdows, based in Melbourne, has a strong commercial acumen and deep experience in all business functions, from supply and manufacturing to marketing and sales. He has a strong strategic and analytical background and experience fulfilling international expansion objectives. Since leaving Heinz, Mr Widdows has advised a successful start-up company, authored two books, and managed his own businesses. Mr Widdows is also a Chartered Accountant and a member of the Australian Institute of Company Directors.
17 years’ experience at Contango Asset Management Ltd in roles including executive director, COO and Company Secretary. Former COO and Executive Director of HSBC Asset Management. Former CFO and Company Secretary of Global Health Ltd